These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17396340)

  • 1. Antibiotic may improve irritable bowel syndrome.
    Mayo Clin Health Lett; 2007 Mar; 25(3):4. PubMed ID: 17396340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness confirmed in studies. Intestine selective antibiotic reduces irritable bowel syndrome effectively].
    Neumaier J
    MMW Fortschr Med; 2010 Oct; 152(43):2 p following 43. PubMed ID: 21171472
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic treatment may ease symptoms of irritable bowel syndrome.
    Mayo Clin Womens Healthsource; 2011 Jun; 15(6):3. PubMed ID: 21540786
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evidence-based therapy of irritable bowel syndrome. Intestine selective antibiotic relieves symptoms significantly].
    MMW Fortschr Med; 2009 May; 151(21):56-7. PubMed ID: 19537640
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation.
    Ponziani FR; Pecere S; Lopetuso L; Scaldaferri F; Cammarota G; Gasbarrini A
    Expert Opin Drug Saf; 2016 Jul; 15(7):983-91. PubMed ID: 27149541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Irritable bowel disease: recent developments].
    Böhm SK; Kruis W
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2034-7. PubMed ID: 23023617
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic treatment of constipation-predominant irritable bowel syndrome: the puzzle is yet to be solved.
    Sachdeva S; Kondala R; Dahale AS; Puri AS
    Dig Dis Sci; 2014 Nov; 59(11):2836-7. PubMed ID: 25217237
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifaximin and lubiprostone: the best options for treating irritable bowel syndrome?
    Purslow C
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):263. PubMed ID: 22816171
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term outcome of rifaximin therapy in non-constipation irritable bowel syndrome.
    Weinstock LB
    Dig Dis Sci; 2011 Nov; 56(11):3389-90. PubMed ID: 21948355
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of patients with irritable bowel syndrome.
    Weinstock LB
    Am Fam Physician; 2007 Jan; 75(1):31. PubMed ID: 17225701
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin.
    DuPont HL; Wolf RA; Israel RJ; Pimentel M
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795384
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifaximin for the treatment of irritable bowel syndrome.
    Cremonini F; Lembo A
    Expert Opin Pharmacother; 2012 Feb; 13(3):433-40. PubMed ID: 22251066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome?
    Stoicescu A; Andrei M; Becheanu G; Stoicescu M; Nicolaie T; Diculescu M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):766-72. PubMed ID: 23272525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteria and the prostate: infertility versus symptoms.
    Pontari MA
    Asian J Androl; 2014; 16(5):784. PubMed ID: 25130580
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifaximin in the treatment of irritable bowel syndrome: is there a high risk for development of antimicrobial resistance?
    Farrell DJ
    J Clin Gastroenterol; 2013 Mar; 47(3):205-11. PubMed ID: 23340064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gut microflora and probiotic effects in the irritable bowel syndrome.
    Fanigliulo L; Comparato G; Aragona G; Cavallaro L; Iori V; Maino M; Cavestro GM; Soliani P; Sianesi M; Franzè A; Di Mario F
    Acta Biomed; 2006 Aug; 77(2):85-9. PubMed ID: 17172187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of Rifaximin in daily clinical practice].
    Bajor J
    Orv Hetil; 2006 Jan; 147(3):139-40. PubMed ID: 16515033
    [No Abstract]   [Full Text] [Related]  

  • 18. Summaries for patients. Can antibiotics improve the symptoms of the irritable bowel syndrome?
    Ann Intern Med; 2006 Oct; 145(8):I24. PubMed ID: 17043334
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy].
    MMW Fortschr Med; 2014 Feb; 156(3):64-5. PubMed ID: 24938070
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibiotic therapy for the irritable bowel syndrome.
    Tack J
    N Engl J Med; 2011 Jan; 364(1):81-2. PubMed ID: 21208112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.